Pfizer Inc.
Ottobock
Bristol-Myers Squibb Co.
Sanofi.
FIOR＆GENTZ
Boehringer Ingelheim International GmbH
Amgen Inc.
Bayer AG
AstraZeneca Plc
Merck and Co. Inc.
Johnson and Johnson Services Inc.
F. Hoffmann-La Roche Ltd.
Myomo
Table of Content
1 Introduction
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2028)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 Key Findings of the Study
3 Market Dynamics
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Stroke Therapeutics Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Stroke Therapeutics Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 Value Chain of the Stroke Therapeutics Market
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)
5 Global Stroke Therapeutics Market-Segmentation by Type
5.1 Equipment and Instruments
5.2 Therapeutic Drugs
6 Global Stroke Therapeutics Market-Segmentation by Application
6.1 Ischemic Stroke
6.2 Hemorrhagic Stroke
7 Global Stroke Therapeutics Market-Segmentation by Marketing Channel
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 Competitive Intelligence - Company Profiles
8.1 Pfizer Inc.
8.1.1 Pfizer Inc. Profile
8.1.2 Pfizer Inc. Sales, Growth Rate and Global Market Share from 2015-2020
8.1.3 Pfizer Inc. Product/Solution Launches and Enhancements Analysis
8.1.4 Pfizer Inc. Business Overview/Recent Development/Acquisitions
8.2 Ottobock
8.2.1 Ottobock Profile
8.2.2 Ottobock Sales, Growth Rate and Global Market Share from 2015-2020
8.2.3 Ottobock Product/Solution Launches and Enhancements Analysis
8.2.4 Ottobock Business Overview/Recent Development/Acquisitions
8.3 Bristol-Myers Squibb Co.
8.3.1 Bristol-Myers Squibb Co. Profile
8.3.2 Bristol-Myers Squibb Co. Sales, Growth Rate and Global Market Share from 2015-2020
8.3.3 Bristol-Myers Squibb Co. Product/Solution Launches and Enhancements Analysis
8.3.4 Bristol-Myers Squibb Co. Business Overview/Recent Development/Acquisitions
8.4 Sanofi.
8.4.1 Sanofi. Profile
8.4.2 Sanofi. Sales, Growth Rate and Global Market Share from 2015-2020
8.4.3 Sanofi. Product/Solution Launches and Enhancements Analysis
8.4.4 Sanofi. Business Overview/Recent Development/Acquisitions
8.5 FIOR＆GENTZ
8.5.1 FIOR＆GENTZ Profile
8.5.2 FIOR＆GENTZ Sales, Growth Rate and Global Market Share from 2015-2020
8.5.3 FIOR＆GENTZ Product/Solution Launches and Enhancements Analysis
8.5.4 FIOR＆GENTZ Business Overview/Recent Development/Acquisitions
8.6 Boehringer Ingelheim International GmbH
8.6.1 Boehringer Ingelheim International GmbH Profile
8.6.2 Boehringer Ingelheim International GmbH Sales, Growth Rate and Global Market Share from 2015-2020
8.6.3 Boehringer Ingelheim International GmbH Product/Solution Launches and Enhancements Analysis
8.6.4 Boehringer Ingelheim International GmbH Business Overview/Recent Development/Acquisitions
8.7 Amgen Inc.
8.7.1 Amgen Inc. Profile
8.7.2 Amgen Inc. Sales, Growth Rate and Global Market Share from 2015-2020
8.7.3 Amgen Inc. Product/Solution Launches and Enhancements Analysis
8.7.4 Amgen Inc. Business Overview/Recent Development/Acquisitions
8.8 Bayer AG
8.8.1 Bayer AG Profile
8.8.2 Bayer AG Sales, Growth Rate and Global Market Share from 2015-2020
8.8.3 Bayer AG Product/Solution Launches and Enhancements Analysis
8.8.4 Bayer AG Business Overview/Recent Development/Acquisitions
8.9 AstraZeneca Plc
8.9.1 AstraZeneca Plc Profile
8.9.2 AstraZeneca Plc Sales, Growth Rate and Global Market Share from 2015-2020
8.9.3 AstraZeneca Plc Product/Solution Launches and Enhancements Analysis
8.9.4 AstraZeneca Plc Business Overview/Recent Development/Acquisitions
8.10 Merck and Co. Inc.
8.10.1 Merck and Co. Inc. Profile
8.10.2 Merck and Co. Inc. Sales, Growth Rate and Global Market Share from 2015-2020
8.10.3 Merck and Co. Inc. Product/Solution Launches and Enhancements Analysis
8.10.4 Merck and Co. Inc. Business Overview/Recent Development/Acquisitions
8.11 Johnson and Johnson Services Inc.
8.11.1 Johnson and Johnson Services Inc. Profile
8.11.2 Johnson and Johnson Services Inc. Sales, Growth Rate and Global Market Share from 2015-2020
8.11.3 Johnson and Johnson Services Inc. Product/Solution Launches and Enhancements Analysis
8.11.4 Johnson and Johnson Services Inc. Business Overview/Recent Development/Acquisitions
8.12 F. Hoffmann-La Roche Ltd.
8.12.1 F. Hoffmann-La Roche Ltd. Profile
8.12.2 F. Hoffmann-La Roche Ltd. Sales, Growth Rate and Global Market Share from 2015-2020
8.12.3 F. Hoffmann-La Roche Ltd. Product/Solution Launches and Enhancements Analysis
8.12.4 F. Hoffmann-La Roche Ltd. Business Overview/Recent Development/Acquisitions
8.13 Myomo
8.13.1 Myomo Profile
8.13.2 Myomo Sales, Growth Rate and Global Market Share from 2015-2020
8.13.3 Myomo Product/Solution Launches and Enhancements Analysis
8.13.4 Myomo Business Overview/Recent Development/Acquisitions
9 Global Stroke Therapeutics Market-Segmentation by Geography
10 North America
10.1 North America Stroke Therapeutics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Stroke Therapeutics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Stroke Therapeutics Production Analysis from 2015-2020
10.4 North America Stroke Therapeutics Consumption Analysis from 2015-2020
10.5 North America Stroke Therapeutics Import and Export from 2015-2020
10.6 North America Stroke Therapeutics Value, Production and Market Share by Type (2015-2020)
10.7 North America Stroke Therapeutics Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Stroke Therapeutics by Country (United States, Canada)
10.8.1 North America Stroke Therapeutics Sales by Country (2015-2020)
10.8.2 North America Stroke Therapeutics Consumption Value by Country (2015-2020)
10.9 North America Stroke Therapeutics Market PEST Analysis
11 Europe
11.1 Europe Stroke Therapeutics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Stroke Therapeutics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Stroke Therapeutics Production Analysis from 2015-2020
11.4 Europe Stroke Therapeutics Consumption Analysis from 2015-2020
11.5 Europe Stroke Therapeutics Import and Export from 2015-2020
11.6 Europe Stroke Therapeutics Value, Production and Market Share by Type (2015-2020)
11.7 Europe Stroke Therapeutics Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Stroke Therapeutics by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe Stroke Therapeutics Sales by Country (2015-2020)
11.8.2 Europe Stroke Therapeutics Consumption Value by Country (2015-2020)
11.9 Europe Stroke Therapeutics Market PEST Analysis
12 Asia-Pacific
12.1 Asia-Pacific Stroke Therapeutics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Stroke Therapeutics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Stroke Therapeutics Production Analysis from 2015-2020
12.4 Asia-Pacific Stroke Therapeutics Consumption Analysis from 2015-2020
12.5 Asia-Pacific Stroke Therapeutics Import and Export from 2015-2020
12.6 Asia-Pacific Stroke Therapeutics Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Stroke Therapeutics Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Stroke Therapeutics by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific Stroke Therapeutics Sales by Country (2015-2020)
12.8.2 Asia-Pacific Stroke Therapeutics Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Stroke Therapeutics Market PEST Analysis
13 Latin America
13.1 Latin America Stroke Therapeutics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Stroke Therapeutics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Stroke Therapeutics Production Analysis from 2015-2020
13.4 Latin America Stroke Therapeutics Consumption Analysis from 2015-2020
13.5 Latin America Stroke Therapeutics Import and Export from 2015-2020
13.6 Latin America Stroke Therapeutics Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Stroke Therapeutics Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Stroke Therapeutics by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America Stroke Therapeutics Sales by Country (2015-2020)
13.8.2 Latin America Stroke Therapeutics Consumption Value by Country (2015-2020)
13.9 Latin America Stroke Therapeutics Market PEST Analysis
14 Middle East & Africa
14.1 Middle East & Africa Stroke Therapeutics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Stroke Therapeutics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Stroke Therapeutics Production Analysis from 2015-2020
14.4 Middle East & Africa Stroke Therapeutics Consumption Analysis from 2015-2020
14.5 Middle East & Africa Stroke Therapeutics Import and Export from 2015-2020
14.6 Middle East & Africa Stroke Therapeutics Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Stroke Therapeutics Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Stroke Therapeutics by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa Stroke Therapeutics Sales by Country (2015-2020)
14.8.2 Middle East & Africa Stroke Therapeutics Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Stroke Therapeutics Market PEST Analysis
15 Future Forecast of the Global Stroke Therapeutics Market from 2020-2028
15.1 Future Forecast of the Global Stroke Therapeutics Market from 2020-2028 Segment by Region
15.2 Global Stroke Therapeutics Production and Growth Rate Forecast by Type (2020-2028)
15.3 Global Stroke Therapeutics Consumption and Growth Rate Forecast by Application (2020-2028)
16 Appendix
16.1 Methodology
16.2 Research Data Source
